| Faith Hospice Of Oklahoma , Inc 921 Nw 164 Street,suite B, Edmond, OK, 73013 | |
| (405) 840-8915 |
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
Researchers from across the world have joined forces to improve the quality of midwifery care and reduce maternal, newborn and infant mortality.
Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.
A joint paper with Kazan State Medical University appeared in Stem Cells International. The research was based at the Gene and Cell Technologies Lab of Kazan University.
The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016.
› Verified 7 days ago
| Name | Faith Hospice Of Oklahoma , Inc |
|---|---|
| Location | 921 Nw 164 Street,suite B, Edmond, Oklahoma |
| Hospice ID | 371630 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 540 |
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
Researchers from across the world have joined forces to improve the quality of midwifery care and reduce maternal, newborn and infant mortality.
Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.
A joint paper with Kazan State Medical University appeared in Stem Cells International. The research was based at the Gene and Cell Technologies Lab of Kazan University.
The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016.
› Verified 7 days ago
| NPI Number | 1144283839 |
| Organization Name | Faith Hospice Of Oklahoma, Inc. |
| Address | 921 Nw 164th St Edmond, Oklahoma, 73013 |
| Phone Number | (405)330-2300 |
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
Researchers from across the world have joined forces to improve the quality of midwifery care and reduce maternal, newborn and infant mortality.
Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.
A joint paper with Kazan State Medical University appeared in Stem Cells International. The research was based at the Gene and Cell Technologies Lab of Kazan University.
The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016.
› Verified 7 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 95.5 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 93.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 78.7 | 93.3 |
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
Researchers from across the world have joined forces to improve the quality of midwifery care and reduce maternal, newborn and infant mortality.
Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.
A joint paper with Kazan State Medical University appeared in Stem Cells International. The research was based at the Gene and Cell Technologies Lab of Kazan University.
The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016.
› Verified 7 days ago
| Home Health Aides | 2 |
| Counselors | 1 |
| Homemakers | 2 |
| Licensed Practical or Vocational Nurses | 6 |
| Medical Social Workers | 2 |
| Physicians | 1 |
| Registered Nurses | 3 |
| Other Personnel | 3 |
| Total Employees | 20 |
|---|
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
Researchers from across the world have joined forces to improve the quality of midwifery care and reduce maternal, newborn and infant mortality.
Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.
A joint paper with Kazan State Medical University appeared in Stem Cells International. The research was based at the Gene and Cell Technologies Lab of Kazan University.
The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016.
› Verified 7 days ago
| Others | 4 |
| Total Volunteers | 4 |
|---|
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
Researchers from across the world have joined forces to improve the quality of midwifery care and reduce maternal, newborn and infant mortality.
Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.
A joint paper with Kazan State Medical University appeared in Stem Cells International. The research was based at the Gene and Cell Technologies Lab of Kazan University.
The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016.
› Verified 7 days ago
| Emerald Hospice, Llc Location: 925 Nw 164th Street, Suite B, Edmond, Oklahoma, 73013 Phone: (405) 840-8915 |
| Faith Hospice Of Oklahoma , Inc Location: 921 Nw 164 Street,suite B, Edmond, Oklahoma, 73013 Phone: (405) 840-8915 |